Page last updated: 2024-10-26

dimethadione and Encephalopathy, Hepatic

dimethadione has been researched along with Encephalopathy, Hepatic in 1 studies

Dimethadione: An anticonvulsant that is the active metabolite of TRIMETHADIONE.

Research Excerpts

ExcerptRelevanceReference
"We evaluated the adequacy of the trimethadione (TMO) tolerance test (the method of estimation from the serum dimethadione [DMO]/TMO ratio, DMO is only one metabolite of TMO, at 4 hours after oral administration of TMO) for estimating the severity of liver damage in 40 cirrhotic patients with and without hepatic encephalopathy."3.68Trimethadione tolerance test for one-point estimation of the severity of liver damage in cirrhotic patients. ( Abei, M; Adachi, S; Fukao, K; Ishikawa, A; Iwasaki, Y; Osada, A; Takase, Y; Tanaka, E; Tsuji, K; Yamamoto, Y, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, E1
Ishikawa, A1
Fukao, K1
Tsuji, K1
Osada, A1
Yamamoto, Y1
Adachi, S1
Takase, Y1
Abei, M1
Iwasaki, Y1

Other Studies

1 other study available for dimethadione and Encephalopathy, Hepatic

ArticleYear
Trimethadione tolerance test for one-point estimation of the severity of liver damage in cirrhotic patients.
    International journal of clinical pharmacology, therapy, and toxicology, 1991, Volume: 29, Issue:8

    Topics: Dimethadione; Female; Hepatic Encephalopathy; Humans; Indocyanine Green; Liver Cirrhosis; Liver Func

1991
chemdatabank.com